Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Leukoplakia, Oral 1

Interventions

Fluorouracil 2Colposcopy 2motexafin lutetium 1fludarabine phosphate 1fludarabine 1aldesleukin 1Vaginal Smears 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Photochemotherapy 1Papanicolaou Test 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Isotretinoin 1Interleukin-2 1Innovar 1Indomethacin 1Imiquimod 1Hydroxyzine 1Granisetron 1Fluorophotometry 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Uterine Cervical Dysplasia × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00005808 2013-02-07

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase 1 Terminated
54 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡